Insider · CIK 0001177917

HARRIGAN EDMUND

Reports to the SEC for 5 companies · WILMINGTON, DE

sec.gov

Transactions

Companies

Filings

CIK

0001177917

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-30	INCYINCYTE CORPA Award	Director	AAward	+206 sh	$121.35	+$25K	23,225
2026-06-30	INCYINCYTE CORPA Award	Director	AAward	+255 sh	$113.36	+$28.9K	23,019
2026-06-08	INCYINCYTE CORPA Award	Director	AAward	+1,642 sh	—	—	22,764
2026-06-08	INCYINCYTE CORP · Non Qualfied Stock Option (right to buy)A Award	Director	AAward	+6,111 sh	—	—	6,111
2026-05-29	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+8,107 sh	—	—	43,148
2026-05-29	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−8,107 sh	—	—	0
2026-05-29	ACADACADIA PHARMACEUTICALS INC · Director Stock Options (Right to Buy)A Award	Director	AAward	+16K sh	—	—	16,004
2026-05-29	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsA Award	Director	AAward	+9,311 sh	—	—	9,311
2026-03-31	INCYINCYTE CORPA Award	Director	AAward	+269 sh	$94.12	+$25.3K	21,122
2025-12-31	INCYINCYTE CORPA Award	Director	AAward	+245 sh	$98.77	+$24.2K	20,853
2025-09-30	INCYINCYTE CORPA Award	Director	AAward	+289 sh	$84.81	+$24.5K	20,608
2025-06-30	INCYINCYTE CORPA Award	Director	AAward	+367 sh	$68.10	+$25K	20,319
2025-06-10	INCYINCYTE CORPA Award	Director	AAward	+2,518 sh	—	—	19,952
2025-06-10	INCYINCYTE CORP · Non Qualfied Stock Option (right to buy)A Award	Director	AAward	+9,216 sh	—	—	9,216
2025-05-29	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+9,387 sh	—	—	35,041
2025-05-29	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−9,387 sh	—	—	0
2025-05-29	ACADACADIA PHARMACEUTICALS INC · Director Stock Options (Right to Buy)A Award	Director	AAward	+13.8K sh	—	—	13,793
2025-05-29	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsA Award	Director	AAward	+8,107 sh	—	—	8,107
2025-03-31	INCYINCYTE CORPA Award	Director	AAward	+363 sh	$60.55	+$22K	17,434
2024-12-31	INCYINCYTE CORPA Award	Director	AAward	+339 sh	$69.07	+$23.4K	17,071
2024-09-30	INCYINCYTE CORPA Award	Director	AAward	+378 sh	$66.10	+$25K	16,732
2024-06-28	INCYINCYTE CORPA Award	Director	AAward	+409 sh	$60.62	+$24.8K	16,354
2024-06-12	INCYINCYTE CORPA Award	Director	AAward	+2,830 sh	—	—	15,945
2024-06-12	INCYINCYTE CORP · Non Qualfied Stock Option (right to buy)A Award	Director	AAward	+12.5K sh	—	—	12,517
2024-05-29	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+6,652 sh	—	—	25,654
2024-05-29	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−6,652 sh	—	—	0
2024-05-29	ACADACADIA PHARMACEUTICALS INC · Director Stock Options (Right to Buy)A Award	Director	AAward	+16K sh	—	—	15,959
2024-05-29	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsA Award	Director	AAward	+9,387 sh	—	—	9,387
2024-03-28	INCYINCYTE CORPA Award	Director	AAward	+413 sh	$56.97	+$23.5K	13,115
2023-12-29	INCYINCYTE CORPA Award	Director	AAward	+423 sh	$62.79	+$26.6K	12,702
2023-09-29	INCYINCYTE CORPA Award	Director	AAward	+389 sh	$57.77	+$22.5K	12,279
2023-06-30	INCYINCYTE CORPA Award	Director	AAward	+390 sh	$62.25	+$24.3K	11,890
2023-06-14	INCYINCYTE CORPA Award	Director	AAward	+2,505 sh	—	—	11,500
2023-06-14	INCYINCYTE CORP · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+11.3K sh	—	—	11,294
2023-06-01	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+8,552 sh	—	—	19,002
2023-06-01	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−8,552 sh	—	—	0
2023-06-01	ACADACADIA PHARMACEUTICALS INC · Director Stock Options (Right to Buy)A Award	Director	AAward	+11K sh	—	—	11,045
2023-06-01	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsA Award	Director	AAward	+6,652 sh	—	—	6,652
2023-05-19	PhaseBio Pharmaceuticals IncM Exercise/Conversion	Director	MExercise/Conversion	+3,750 sh	—	—	9,750
2023-05-19	PhaseBio Pharmaceuticals IncRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	+3,750 sh	—	—	0
2023-03-31	INCYINCYTE CORPA Award	Director	AAward	+326 sh	$72.27	+$23.6K	8,995
2022-12-30	INCYINCYTE CORPA Award	Director	AAward	+302 sh	$80.32	+$24.3K	8,669
2022-10-19	INCYINCYTE CORPA Award	Director	AAward	+165 sh	$69.59	+$11.5K	8,367
2022-09-30	INCYINCYTE CORPA Award	Director	AAward	+250 sh	$66.64	+$16.7K	8,202
2022-06-30	INCYINCYTE CORPA Award	Director	AAward	+236 sh	$75.97	+$17.9K	7,952
2022-06-15	INCYINCYTE CORPA Award	Director	AAward	+2,144 sh	—	—	7,716
2022-06-15	INCYINCYTE CORP · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+9,124 sh	—	—	9,124
2022-06-07	ACADACADIA PHARMACEUTICALS INC · Director Stock Options (Right to Buy)A Award	Director	AAward	+14.4K sh	—	—	14,368
2022-06-07	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsA Award	Director	AAward	+8,552 sh	—	—	8,552
2022-06-07	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+6,391 sh	—	—	10,450

Recent filings

Accepted (ET)
Oct 24
HARRIGAN EDMUND0001177917-26-000014
SEC(opens sec.gov)
Jul 24
HARRIGAN EDMUND0001177917-26-000012
SEC(opens sec.gov)
Jun 104
HARRIGAN EDMUND0001177917-26-000011
SEC(opens sec.gov)
Jun 14
HARRIGAN EDMUND0001177917-26-000009
SEC(opens sec.gov)
Apr 24
HARRIGAN EDMUND0001177917-26-000006
SEC(opens sec.gov)
Jan 54
HARRIGAN EDMUND0001177917-26-000002
SEC(opens sec.gov)
Oct 24
HARRIGAN EDMUND0001177917-25-000004
SEC(opens sec.gov)
Jul 24
HARRIGAN EDMUND0000879169-25-000069
SEC(opens sec.gov)
Jun 124
HARRIGAN EDMUND0001628280-25-030999
SEC(opens sec.gov)
Jun 24
HARRIGAN EDMUND0001415889-25-015273
SEC(opens sec.gov)
Apr 24
HARRIGAN EDMUND0001628280-25-016170
SEC(opens sec.gov)
Jan 34
HARRIGAN EDMUND0000879169-25-000003
SEC(opens sec.gov)

Companies

Address

1801 AUGUSTINE CUT-OFF

WILMINGTON, DE, 19803